Tokyo Tape
Sign in
← Euglena

Annual report

2931.TEDINET S100QG7X
Period2022-01-01 → 2022-12-31
Filed2023-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 64
MetricValuePeriodScopeSource row
Revenue¥44.4bn2022-01-01 → 2022-12-31Cons.Net sales
Revenue¥34.4bn2020-10-01 → 2021-12-31Cons.Net sales
Operating income−¥3.5bn2022-01-01 → 2022-12-31Cons.Operating income
Operating income−¥6.6bn2020-10-01 → 2021-12-31Cons.Operating income
Ordinary income−¥2.5bn2022-01-01 → 2022-12-31Cons.Ordinary income
Ordinary income−¥6.4bn2020-10-01 → 2021-12-31Cons.Ordinary income
Profit before tax−¥2.4bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Profit before tax−¥6.7bn2020-10-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥5.0bn2020-10-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss
Net income−¥5.8bn2020-10-01 → 2021-12-31Cons.Profit loss
Total assets¥57.3bnat 2022-12-31Cons.Assets
Total assets¥61.0bnat 2021-12-31Cons.Assets
Total liabilities¥37.9bnat 2022-12-31Cons.Liabilities
Total liabilities¥40.4bnat 2021-12-31Cons.Liabilities
Net assets / equity¥19.4bnat 2022-12-31Cons.Net assets
Net assets / equity¥20.6bnat 2021-12-31Cons.Net assets
Cash and deposits¥10.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥9.9bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥9.8bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥9.8bnat 2021-12-31Cons.Cash and cash equivalents
Operating cash flow¥924m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.4bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow¥1.2bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.3bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥12.1bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-23.832022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.072020-10-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
Net assets per share¥167.34at 2022-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥181.35at 2021-12-31Cons.Net assets per share (5-year summary)
Equity ratio33.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Employees865at 2022-12-31Cons.Number of employees
Employees883at 2021-12-31Cons.Number of employees
Revenue¥6.5bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥9.5bn2020-10-01 → 2021-12-31StandaloneNet sales
Operating income−¥3.5bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income−¥3.4bn2020-10-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥2.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥2.6bn2020-10-01 → 2021-12-31StandaloneOrdinary income
Profit before tax−¥2.6bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥2.7bn2020-10-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥2.7bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥2.4bn2020-10-01 → 2021-12-31StandaloneProfit loss
Total assets¥26.7bnat 2022-12-31StandaloneAssets
Total assets¥27.8bnat 2021-12-31StandaloneAssets
Total liabilities¥5.2bnat 2022-12-31StandaloneLiabilities
Total liabilities¥5.5bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥21.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥22.3bnat 2021-12-31StandaloneNet assets
Cash and deposits¥2.9bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.9bnat 2021-12-31StandaloneCash and deposits
EPS (basic)¥-23.92022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-22.942020-10-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥186.11at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥197.18at 2021-12-31StandaloneNet assets per share (5-year summary)
Equity ratio78.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.8%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued113,105,455at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued111,161,886at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Employees250at 2022-12-31StandaloneNumber of employees
Employees212at 2021-12-31StandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-01-01 → 2022-12-31¥1m
Reconciling Itemsreconcilingdepreciation2022-01-01 → 2022-12-31¥50m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥3.4bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥1.7bn
Biofuel Businessreportable segmentcapex2022-01-01 → 2022-12-31¥22m
Biofuel Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥49m
Biofuel Businessreportable segmentemployeesat 2022-12-3143 pure
Biofuel Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥262m
Biofuel Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥262m
Biofuel Businessreportable segmentsegment assetsat 2022-12-31¥947m
Biofuel Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥789m
Health Care Businessreportable segmentcapex2022-01-01 → 2022-12-31¥406m
Health Care Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥2.2bn
Health Care Businessreportable segmentemployeesat 2022-12-31655 pure
Health Care Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥41.6bn
Health Care Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥41.6bn
Health Care Businessreportable segmentsegment assetsat 2022-12-31¥49.6bn
Health Care Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥638m
Others Businessreportable segmentcapex2022-01-01 → 2022-12-31¥48m
Others Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥34m
Others Businessreportable segmentemployeesat 2022-12-31113 pure
Others Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥2.5bn
Others Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥2.5bn
Others Businessreportable segmentsegment assetsat 2022-12-31¥3.3bn
Others Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥325m
—segment totalcapex2022-01-01 → 2022-12-31¥477m
—segment totaldepreciation2022-01-01 → 2022-12-31¥2.3bn
—segment totalrevenue2022-01-01 → 2022-12-31¥44.4bn
—segment totalrevenue external2022-01-01 → 2022-12-31¥44.4bn
—segment totalsegment assetsat 2022-12-31¥53.9bn
—segment totalsegment profit2022-01-01 → 2022-12-31−¥1.8bn
Reconciling Itemsreconcilingcapex2020-10-01 → 2021-12-31¥31m
Reconciling Itemsreconcilingdepreciation2020-10-01 → 2021-12-31¥94m
Reconciling Itemsreconcilingsegment assetsat 2021-12-31¥5.7bn
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-12-31−¥2.2bn
Biofuel Businessreportable segmentcapex2020-10-01 → 2021-12-31¥37m
Biofuel Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥110m
Biofuel Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥47m
Biofuel Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥47m
Biofuel Businessreportable segmentsegment assetsat 2021-12-31¥602m
Biofuel Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥1.2bn
Health Care Businessreportable segmentcapex2020-10-01 → 2021-12-31¥387m
Health Care Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥1.5bn
Health Care Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥33.7bn
Health Care Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥33.7bn
Health Care Businessreportable segmentsegment assetsat 2021-12-31¥52.1bn
Health Care Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥2.8bn
Others Businessreportable segmentcapex2020-10-01 → 2021-12-31¥54m
Others Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥14m
Others Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥627m
Others Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥627m
Others Businessreportable segmentsegment assetsat 2021-12-31¥2.6bn
Others Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥373m
—segment totalcapex2020-10-01 → 2021-12-31¥479m
—segment totaldepreciation2020-10-01 → 2021-12-31¥1.6bn
—segment totalrevenue2020-10-01 → 2021-12-31¥34.4bn
—segment totalrevenue external2020-10-01 → 2021-12-31¥34.4bn
—segment totalsegment assetsat 2021-12-31¥55.3bn
—segment totalsegment profit2020-10-01 → 2021-12-31−¥4.4bn
Biofuel Businessreportable segmentemployeesat 2022-12-3143 pure
Health Care Businessreportable segmentemployeesat 2022-12-31127 pure
Others Businessreportable segmentemployeesat 2022-12-3125 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,625
ItemContextValueUnit
Net cash provided by used in operating activitiesPrior1YearDuration1378000000JPY
Net cash provided by used in operating activitiesCurrentYearDuration924000000JPY
Decrease increase in time deposits inv cfPrior1YearDuration-80000000JPY
Decrease increase in time deposits inv cfCurrentYearDuration-60000000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration-198000000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration-329000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YearDuration0JPY
Proceeds from sales of property plant and equipment inv cfCurrentYearDuration696000000JPY
Purchase of intangible assets inv cfPrior1YearDuration-246000000JPY
Purchase of intangible assets inv cfCurrentYearDuration-167000000JPY
Purchase of investment securities inv cfPrior1YearDuration-5000000JPY
Purchase of investment securities inv cfCurrentYearDuration-67000000JPY
Proceeds from sales and redemption of investment securities inv cfPrior1YearDuration－JPY
Proceeds from sales and redemption of investment securities inv cfCurrentYearDuration462000000JPY
Decrease increase in short term loans receivable inv cfPrior1YearDuration3000000JPY
Decrease increase in short term loans receivable inv cfCurrentYearDuration-78000000JPY
Collection of long term loans receivable inv cfPrior1YearDuration0JPY
Collection of long term loans receivable inv cfCurrentYearDuration130000000JPY
Payments for guarantee deposits inv cfPrior1YearDuration-15000000JPY
Payments for guarantee deposits inv cfCurrentYearDuration-12000000JPY
Proceeds from collection of guarantee deposits inv cfPrior1YearDuration73000000JPY
Proceeds from collection of guarantee deposits inv cfCurrentYearDuration4000000JPY
Payments for asset retirement obligations inv cfPrior1YearDuration-31000000JPY
Payments for asset retirement obligations inv cfCurrentYearDuration－JPY
Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YearDuration-9838000000JPY
Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYearDuration－JPY
Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YearDuration－JPY
Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYearDuration654000000JPY
Net cash provided by used in investment activitiesPrior1YearDuration-10338000000JPY
Net cash provided by used in investment activitiesCurrentYearDuration1233000000JPY
Increase decrease in short term loans payable fin cfPrior1YearDuration28000000JPY
Increase decrease in short term loans payable fin cfCurrentYearDuration274000000JPY
Proceeds from long term loans payable fin cfPrior1YearDuration610000000JPY
Proceeds from long term loans payable fin cfCurrentYearDuration594000000JPY
Repayment of long term loans payable fin cfPrior1YearDuration-1510000000JPY
Repayment of long term loans payable fin cfCurrentYearDuration-3843000000JPY
Repayments of lease obligations fin cfPrior1YearDuration-6000000JPY
Repayments of lease obligations fin cfCurrentYearDuration-12000000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration12940000000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration－JPY
Dividends paid to non controlling interests fin cfPrior1YearDuration－JPY
Dividends paid to non controlling interests fin cfCurrentYearDuration-5000000JPY
Purchase of treasury stock fin cfPrior1YearDuration－JPY
Purchase of treasury stock fin cfCurrentYearDuration-0JPY
Net cash provided by used in financing activitiesPrior1YearDuration12062000000JPY
Net cash provided by used in financing activitiesCurrentYearDuration-2993000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration4000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration3000000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration3106000000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration-831000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 22 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution partial
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2020-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2020-10-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2020-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass